ECOG-ACRIN renames health equity scholarships in honor of Edith Mitchell

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

Fatemeh ArdeshirAndrew SrisuwananukornFatemeh Ardeshir and Andrew Srisuwananukorn, two presenters from the 23rd annual Young Investigator Symposium of the ECOG-ACRIN Cancer Research Group have received awards of distinction—a yearly tradition.

November 03, 2023

Vol.49 No.41

In Brief

Patrick M. Forde, Arlene A. Forastiere, Julia D. Ransohoff receive ECOG-ACRIN 2023 scientific leadership and mentorship awards

Patrick M. FordeArlene A. ForastiereJulia D. RansohoffPatrick M. Forde, Arlene A. Forastiere, and Julia D. Ransohoff were named recipients of the ECOG-ACRIN Cancer Research Group 2023 scientific leadership and mentorship awards.

May 26, 2023

Vol.49 No.21

NCI Director's Report

“Your work makes the rest of it work,” NCI Director Bertagnolli says to clinical trialists at ECOG-ACRIN meeting

In her first public speech as NCI director, Monica Bertagnolli said that under her stewardship NCI would modernize clinical trials and double patient accrual.

Selina Luger named chair of ECOG-ACRIN Leukemia Committee

Selina M. Luger, a hematologist-oncologist and acute leukemia and myeloid disorders researcher, was appointed chair of the ECOG-ACRIN Cancer Research Group Leukemia Committee.

October 28, 2022

Vol.48 No.39

In Brief

Jennifer Eads, Andrew Srisuwananukorn granted ECOG-ACRIN awards

Jennifer R. Eads earned the ECOG-ACRIN Young Investigator Award for 2022.

May 13, 2022

Vol.48 No.19

Clinical Roundup

ECOG-ACRIN opens NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

The NCI-MATCH trial offers treatment opportunities for adult patients with relapsed, refractory cancers. A new treatment arm (Z1M) is evaluating the immunotherapy combination of relatlimab and nivolumab in patients whose tumors have mismatch repair deficiency and LAG-3 expression and have progressed after anti–PD-1/PD-L1 immunotherapy.

March 18, 2022

Vol.48 No.11

ECOG-ACRIN renames health equity scholarships in honor of Edith Mitchell

YOU MAY BE INTERESTED IN

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

Patrick M. Forde, Arlene A. Forastiere, Julia D. Ransohoff receive ECOG-ACRIN 2023 scientific leadership and mentorship awards

“Your work makes the rest of it work,” NCI Director Bertagnolli says to clinical trialists at ECOG-ACRIN meeting

Selina Luger named chair of ECOG-ACRIN Leukemia Committee

Jennifer Eads, Andrew Srisuwananukorn granted ECOG-ACRIN awards

ECOG-ACRIN opens NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Renew today!

Subscriber content

Login